Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3808537 | 0.96 | CACNA1G (0.34) | RXFP1CHRM5TAS2R14PTGDR2FKBP1A | |
| SCHEMBL3665336 | 0.95 | CHRM5 (0.36) | CHRM5CACNA1GCACNA1H | |
| SCHEMBL3667342 | 0.94 | CHRM1 (0.34) | RXFP1CHRM5TAS2R14PTGDR2ALDH1A1 | |
| SCHEMBL3671643 | 0.91 | CHRM5 (0.39) | CHRM5TAS2R14PTGDR2ALDH1A1KDM4E | |
| SCHEMBL4735430 | 0.91 | CACNA1G (0.35) | RXFP1FKBP1AKDM4EL3MBTL1CACNA1G | |
| SCHEMBL4800257 | 0.88 | OPRL1 (0.36) | CACNA1GCACNA1H | |
| SCHEMBL3665332 | 0.86 | POLB (0.35) | CHRM5ALDH1A1CACNA1GCACNA1H | |
| SCHEMBL4737981 | 0.86 | CACNA1G (0.33) | CHRM5CACNA1GCACNA1H | |
| SCHEMBL4796833 | 0.85 | POLB (0.41) | ALDH1A1 | |
| SCHEMBL4675598 | 0.81 | CYP3A4 (0.40) | CACNA1GCACNA1HACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155676-A2 | COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS | Commissariat à l'Energie Atomique (FR) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008146172-A2 | COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-12-04 | — | — | WO | disclosed |